Effect of Soy Intake on Cardiovascular Disease Biomarkers in Subclinical Hypothyroid Participants

Withdrawn before enrolling · Not applicable

Conditions studied: Cardiovascular Disease, Subclinical Hypothyroid

In brief

The purpose of this study is to help the researchers understand if using a soy supplement impacts cardiovascular disease risk factors in patients with subclinical hypothyroidism.

Key facts

Study ID

NCT02024906

Run by

Jill Hamilton-Reeves, PhD RD LD

People needed

0

Starts

2015-02-01

Expected to finish

2015-09-01

Last updated by the study team

2015-09-23

Who can join

Age: 25 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with subclinical hypothyroidism (otherwise healthy volunteers)
• Adults aged 25 - 70 yrs.
• Willing to avoid consumption of soy/other isoflavone containing foods (i.e. some snack bars) during the study.
• Willing to avoid consumption of dietary (other than multivitamin) and herbal supplements during the study.

You may not qualify if…

• Taking drugs that interfere with thyroid function
• Planning pregnancy in the next 6 months
• Taking drugs that lower lipids, blood pressure, or sensitize insulin
• Regular consumption of soy products (>20 g/wk)
• Consumption of soyfoods within 90 days prior to enrollment.
• Known history of soy or milk allergy or intolerance.
• Taking antibiotics during the intervention
• Active viral infections such as Human immunodeficiency virus (HIV) positive or hepatitis

Where it is running

• University of Kansas Medical Center — Kansas City, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.